+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Minimal Invasive Spinal Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 64 Pages
  • August 2023
  • Region: Global
  • GlobalData
  • ID: 5876330
The Medical Devices sector report, “Minimal Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Minimal Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimal Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Minimal Invasive Spinal Devices Overview
3 Products under Development
3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
3.6 Minimal Invasive Spinal Devices - Ongoing Clinical Trials
4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies
4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
5 Minimal Invasive Spinal Devices Companies and Product Overview
6 Minimal Invasive Spinal Devices- Recent Developments
6.1 Jul 05, 2023: Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures
6.2 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call
6.3 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call
6.4 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board
6.5 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
6.6 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
  • Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bonovo Orthopedics Inc
  • Camber Spine Technologies LLC
  • Corelink LLC
  • CTL Amedica Corp
  • DePuy Synthes Inc
  • Discure Technologies Ltd
  • EIT Emerging Implant Technologies GmbH
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Implanet SA
  • Inion Oy
  • Integra LifeSciences Holdings Corp
  • Intelligent Implants
  • Maxigen Biotech Inc
  • MicroPort Scientific Corp
  • OrthoPediatrics Corp
  • Osseus Fusion Systems LLC
  • OxSonics Ltd
  • Safe SA
  • SeaSpine, Inc.
  • Spinal Balance Inc.
  • Stryker Corp
  • SurGenTec LLC
  • The Chaim Sheba Medical Center
  • University of South Florida
  • University of Toledo
  • Vivonics Inc
  • ZuriMED Technologies AG